Applications of Quantitative Systems Pharmacology in Model-Informed Drug Discovery: Perspective on Impact and Opportunities.
Clicks: 297
ID: 48465
2019
Over the past decade, quantitative systems pharmacology (QSP) has gained traction within the pharmaceutical industry as a modeling method to quantitatively and mechanistically describe diseases and the complexity of drug action. The preclinical QSP working group, within the Translational and ADME Sciences Leadership Group (TA LG), as part of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), was formed in 2016 to bring together representatives across the pharmaceutical industry with objectives to share knowledge, assess the current landscape of QSP modeling in the preclinical space of research and development, and discuss/align on best practices.
| Reference Key |
bradshaw2019applicationscpt
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bradshaw, Erica L;Spilker, Mary E;Zang, Richard;Bansal, Loveleena;He, Handan;DO Jones, Rhys;Le, Kha;Penney, Mark;Schuck, Edgar;Topp, Brian;Tsai, Alice;Xu, Christine;J M A Nijsen, Marjoleen;Chan, Jason R; |
| Journal | cpt: pharmacometrics & systems pharmacology |
| Year | 2019 |
| DOI | 10.1002/psp4.12463 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.